Keyphrases
Acute Lymphoblastic Leukemia
100%
High Incidence
100%
Second Malignant Neoplasm
100%
Second Malignancy
100%
NUDT15
100%
6-mercaptopurine (6-MP)
75%
Confidence Interval
25%
Cumulative Incidence
12%
Cancer Genes
12%
DNA Damage
12%
Mutational Signatures
12%
In Cancer
12%
Knockdown
12%
Whole Exome Sequencing
12%
Childhood Leukemia
12%
Genetic Variation
12%
Hypomorphic mutation
12%
Pathogenic Germline Variant
12%
Leukemia-lymphoma
12%
Induced Pluripotent Stem Cells (iPSCs)
12%
Validation Studies
12%
Unselected Patients
12%
Metabolic Genes
12%
East Asia
12%
GnomAD
12%
Medicine and Dentistry
Malignant Neoplasm
100%
Acute Lymphoblastic Leukemia
100%
Second Cancer
100%
Mercaptopurine
66%
Prevalence
22%
Cumulative Incidence
11%
Exome Sequencing
11%
Childhood Leukemia
11%
Genetic Variation
11%
DNA Damage
11%
Population
11%
Induced Pluripotent Stem Cell
11%
Germ Cell
11%
Immunology and Microbiology
Prevalence
100%
DNA Damage
50%
Population
50%
Whole Exome Sequencing
50%
Genetic Variation
50%
Induced Pluripotent Stem Cell
50%
Germ Cell
50%
Biochemistry, Genetics and Molecular Biology
Mercaptopurine
100%
Prevalence
33%
Germline
16%
Germ Cell
16%
DNA Damage
16%
Genetic Divergence
16%
Exome Sequencing
16%
Population
16%
Genetic Variation
16%
Induced Pluripotent Stem Cell
16%